To include your compound in the COVID-19 Resource Center, submit it here.

Cellectis, Takara Bio deal

Cellectis sold its Cellectis AB subsidiary to Takara. The subsidiary is focused on applications of

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE